Paper7544516
Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia.
Napalkov P and 2 others. Urology, 1995. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia. Papers, record 7544516. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7544516
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostatic Hyperplasia | Major topic |
| Global Health | |
| Humans | |
| Male | |
| Prevalence | |
| Risk Factors |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42337003 | Perceived partner responsiveness between benign prostatic hyperplasia's symptom index and aging male symptoms. | Sci Rep | 2026 | https://conductscience.org/library/papers/42337003 | PubMed |
| 42174115 | Antifibrotic therapy for Lower Urinary Tract Symptoms secondary to Benign Prostatic Hyperplasia. | Prostate Cancer Prostatic Dis | 2025 | https://conductscience.org/library/papers/42174115 | PubMed |
| 38298771 | Incidence of Surgical Reintervention for Benign Prostatic Hyperplasia Following Prostatic Urethral Lift, Transurethral Resection of the Prostate, and Photoselective Vaporization of the Prostate: A TriNetX Analysis. | Eur Urol Open Sci | 2024 | https://conductscience.org/library/papers/38298771 | PubMed |
| 36821011 | Safety and efficacy of GreenLight PVP in octogenarians: evaluation of the Global GreenLight Group database. | World J Urol | 2023 | https://conductscience.org/library/papers/36821011 | PubMed |
| 33425801 | Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers. | Transl Clin Pharmacol | 2020 | https://conductscience.org/library/papers/33425801 | PubMed |
| 32110593 | Study of correlation of urodynamic profile with symptom scoring and ultrasonographic parameters in patients with benign prostatic hyperplasia. | J Family Med Prim Care | 2020 | https://conductscience.org/library/papers/32110593 | PubMed |
| 31218458 | Cost Comparison of Benign Prostatic Hyperplasia Treatment Options. | Curr Urol Rep | 2019 | https://conductscience.org/library/papers/31218458 | PubMed |
| 30710233 | The effects of Pueraria mirifica extract, diadzein and genistein in testosterone-induced prostate hyperplasia in male Sprague Dawley rats. | Mol Biol Rep | 2019 | https://conductscience.org/library/papers/30710233 | PubMed |
| 30608454 | Herbal medicine for benign prostatic hyperplasia: A protocol for a systematic review of controlled trials. | Medicine (Baltimore) | 2019 | https://conductscience.org/library/papers/30608454 | PubMed |
| 25491675 | Demographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different? | World J Urol | 2015 | https://conductscience.org/library/papers/25491675 | PubMed |
| 22496707 | The effects of transurethral resection of the prostate on morbidity and mortality in patients with nondialysis-requiring renal insufficiency. | Ther Adv Urol | 2012 | https://conductscience.org/library/papers/22496707 | PubMed |
| 21557268 | 5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression. | Prostate | 2011 | https://conductscience.org/library/papers/21557268 | PubMed |
| 19545384 | The psychometric validation of a US English satisfaction measure for patients with benign prostatic hyperplasia and lower urinary tract symptoms. | Health Qual Life Outcomes | 2009 | https://conductscience.org/library/papers/19545384 | PubMed |
| 17516689 | Efficacy of low-dose tamsulosin on lower urinary tract symptoms suggestive of benign prostatic hyperplasia : a nonblind multicentre korean study. | Clin Drug Investig | 2004 | https://conductscience.org/library/papers/17516689 | PubMed |
| 17341729 | A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease. | J Natl Cancer Inst | 2007 | https://conductscience.org/library/papers/17341729 | PubMed |
| 16985831 | Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase. | Rev Urol | 2005 | https://conductscience.org/library/papers/16985831 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7544516
GET https://conductscience.org/api/papers/v1/7544516/authors